chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Headache, Lymphadenopathy, Oropharyngeal pain, Pain, Pyrexia
Clinical narrative: sore throat; body ache; fever; headache; Swollen lymph node; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (sore throat), PAIN (body ache), PYREXIA (fever), HEADACHE (headache) and LYMPHADENOPATHY (Swollen lymph node) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 09L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jan-2021, the patient experienced OROPHARYNGEAL PAIN (sore throat), PAIN (body ache), PYREXIA (fever), HEADACHE (headache) and LYMPHADENOPATHY (Swollen lymph node). At the time of the report, OROPHARYNGEAL PAIN (sore throat), PAIN (body ache), PYREXIA (fever), HEADACHE (headache) and LYMPHADENOPATHY (Swollen lymph node) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications reported by investigator No treatment medications provided by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2021-022474, US-MODERNATX, INC.-MOD-2021-047944 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-047944:Crosslinked (MOD21-018080) US-MODERNATX, INC.-MOD-2021-022474:Crosslinked (MOD21-018080)
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Nausea, Pain, Pyrexia
Clinical narrative: aches; fever; queasy stomach; headache; A spontaneous report was received from a Consumer concerning a 64-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events aches, fever, headache, queasy stomach.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On unknown date (approximately four weeks ago from the day of reporting), the patient received their first of two planned doses of mRNA-1273 (lot batch: not provided) intramuscularly for prophylaxis of COVID-19 infection.  On unknown date (reported as yesterday on the day of reporting),  prior to the onset of the events the patient received their second of two planned doses of mRNA-1273 (lot batch: not provided) intramuscularly for prophylaxis of COVID-19 infection.  On an unknown date, 1 day after administration of second dose of mRNA-1273 , the patient experienced the events aches, fever, headache, queasy stomach.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not applicable.   The outcome of events include, aches, fever, headache, queasy stomach was considered as unknown.; Reporter's Comments: Based on the current available information which includes a strong temporal association between the use of the product and the start date of the reported event, and the known safety profile of mRNA-1273, a causal relationship with the event cannot be excluded.  Fever, nausea and  headache are consistent with  the product safety profile.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Dysgeusia, Muscle contractions involuntary, Myalgia, Pain in extremity
Clinical narrative: Feels a little achy; Funny taste in her mouth; Slight quivering in her bottom lip; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of the first episode of DYSGEUSIA (Funny taste in her mouth), MUSCLE CONTRACTIONS INVOLUNTARY (Slight quivering in her bottom lip), PAIN IN EXTREMITY (Sore arm), MYALGIA (Feels a little achy) and the second episode of DYSGEUSIA (Funny taste in her mouth) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced the first episode of DYSGEUSIA (Funny taste in her mouth), MUSCLE CONTRACTIONS INVOLUNTARY (Slight quivering in her bottom lip), PAIN IN EXTREMITY (Sore arm) and the second episode of DYSGEUSIA (Funny taste in her mouth). On 28-Jan-2021, the patient experienced MYALGIA (Feels a little achy). On 28-Jan-2021, MUSCLE CONTRACTIONS INVOLUNTARY (Slight quivering in her bottom lip), PAIN IN EXTREMITY (Sore arm) and the last episode of DYSGEUSIA (Funny taste in her mouth) had resolved. At the time of the report, MYALGIA (Feels a little achy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Scratch, Vaccination site pain, Vaccination site pruritus
Clinical narrative: When area at injection site is scratched it puffs up to about 3 inches in diameter; Itchy at injection site; Small pain in left arm at injection site; This spontaneous case was reported by a consumer and describes the occurrence of SCRATCH (When area at injection site is scratched it puffs up to about 3 inches in diameter), VACCINATION SITE PRURITUS (Itchy at injection site) and VACCINATION SITE PAIN (Small pain in left arm at injection site) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported).    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SCRATCH (When area at injection site is scratched it puffs up to about 3 inches in diameter), VACCINATION SITE PRURITUS (Itchy at injection site) and VACCINATION SITE PAIN (Small pain in left arm at injection site). At the time of the report, SCRATCH (When area at injection site is scratched it puffs up to about 3 inches in diameter), VACCINATION SITE PRURITUS (Itchy at injection site) and VACCINATION SITE PAIN (Small pain in left arm at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant and treatment information not provided  Company comment:Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Erythema, Fatigue, Headache, Lymphadenopathy
Clinical narrative: redness; headache; swelling on lymp node; fatigue; Tenderness; diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of TENDERNESS (Tenderness), DIARRHOEA (diarrhea), FATIGUE (fatigue), ERYTHEMA (redness) and HEADACHE (headache) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included PRAVASTATIN for an unknown indication.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced TENDERNESS (Tenderness) and DIARRHOEA (diarrhea). On 18-Jan-2021, the patient experienced FATIGUE (fatigue). On 25-Jan-2021, the patient experienced ERYTHEMA (redness), HEADACHE (headache) and LYMPHADENOPATHY (swelling on lymp node). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 15-Jan-2021, TENDERNESS (Tenderness) had resolved. On 23-Jan-2021, FATIGUE (fatigue) had resolved. On 01-Feb-2021, LYMPHADENOPATHY (swelling on lymp node) had resolved. At the time of the report, DIARRHOEA (diarrhea), ERYTHEMA (redness) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Tenderness
Clinical narrative: redness; headache; swelling on lymp node; fatigue; Tenderness; diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of TENDERNESS (Tenderness), DIARRHOEA (diarrhea), FATIGUE (fatigue), ERYTHEMA (redness) and HEADACHE (headache) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included PRAVASTATIN for an unknown indication.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced TENDERNESS (Tenderness) and DIARRHOEA (diarrhea). On 18-Jan-2021, the patient experienced FATIGUE (fatigue). On 25-Jan-2021, the patient experienced ERYTHEMA (redness), HEADACHE (headache) and LYMPHADENOPATHY (swelling on lymp node). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 15-Jan-2021, TENDERNESS (Tenderness) had resolved. On 23-Jan-2021, FATIGUE (fatigue) had resolved. On 01-Feb-2021, LYMPHADENOPATHY (swelling on lymp node) had resolved. At the time of the report, DIARRHOEA (diarrhea), ERYTHEMA (redness) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Malaise, Pain, Pain in extremity, Pyrexia
Clinical narrative: Fever; chills; achiness; arm hurts; didn't feel well; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), CHILLS (chills), PAIN (achiness), PAIN IN EXTREMITY (arm hurts) and MALAISE (didn't feel well) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included INDOMETACIN SODIUM TRIHYDRATE (INDOMETHACIN AGILA), LISINOPRIL and METOPROLOL for an unknown indication.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced PYREXIA (Fever), CHILLS (chills), PAIN (achiness), PAIN IN EXTREMITY (arm hurts) and MALAISE (didn't feel well). At the time of the report, PYREXIA (Fever), CHILLS (chills), PAIN (achiness), PAIN IN EXTREMITY (arm hurts) and MALAISE (didn't feel well) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information provided.; Reporter's Comments: Based on the current available information which includes a temporal association between the use of the product and onset of the event, a causal relationship cannot be excluded. Chills and fever are consistent with the product safety profile.
Sex: M
Vaccine: COVID19
Symptoms: Inflammation
Clinical narrative: did not report adverse event but the inflammation could be suspected as an Potential Adverse event; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of INFLAMMATION (did not report adverse event but the inflammation could be suspected as an Potential Adverse event) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jan-2021, the patient experienced INFLAMMATION (did not report adverse event but the inflammation could be suspected as an Potential Adverse event). The patient was treated with METHYLPREDNISOLONE (MEDROL [METHYLPREDNISOLONE]) for Inflammation, at an unspecified dose and frequency. At the time of the report, INFLAMMATION (did not report adverse event but the inflammation could be suspected as an Potential Adverse event) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No relevant concomitant medications were reported. inflammation was a potential suspected adverse event since Medrol was prescribed for inflammation.
Sex: M
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: sore arm; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (sore arm) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) injection for an unknown indication.     The patient's past medical history included No adverse event.    On an unknown date, the patient started mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced MYALGIA (sore arm). At the time of the report, MYALGIA (sore arm) outcome was unknown.            Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.   Reporter did not allow further contact; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Sex: U
Vaccine: COVID19
Symptoms: Body temperature, Chills, Pyrexia
Clinical narrative: Teeth chattering; 103 fever; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Teeth chattering) and PYREXIA (103 fever) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced CHILLS (Teeth chattering) and PYREXIA (103 fever). At the time of the report, CHILLS (Teeth chattering) and PYREXIA (103 fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 103 degree Celsius (High) High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications was reported. Treatment details included Not provided
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Arm pain; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Arm pain) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Jan-2021, the patient experienced VACCINATION SITE PAIN (Arm pain). At the time of the report, VACCINATION SITE PAIN (Arm pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Sex: M
Vaccine: COVID19
Symptoms: Limb discomfort
Clinical narrative: Discomfort in the axillary zone of the arm; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (Discomfort in the axillary zone of the arm) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced LIMB DISCOMFORT (Discomfort in the axillary zone of the arm). At the time of the report, LIMB DISCOMFORT (Discomfort in the axillary zone of the arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Relevant concomitant medications were unknown. Treatment details were not provided.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Contusion, Dizziness, Feeling abnormal, Pain, Tinnitus
Clinical narrative: Bruises; Dizziness / light headedness; Feeling of ringing ears; ringing in ears; Little soreness; A spontaneous report was received from a consumer concerning a 72-year-old, male patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced little soreness / pain.  The patient's medical history and concomitant medications were not provided by the reporter.  On 14 Feb 2021, approximately one day prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Lot number: unknown) for prophylaxis of COVID-19 infection. The route of administration and anatomical location of vaccine administration was not provided.  On 15 Feb 2021, the patient experienced little soreness.  Treatment information was not provided.  Action taken with mRNA-1273 in response to the events was not reported.  The event, little soreness was resolved on 15 Feb 2021.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling jittery, Headache, Nausea, Pain in extremity, Pyrexia
Clinical narrative: jittery; headache; nausea; Fever of 100.1F (3 degrees warmer than typical temperature).; arm really sore; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 19-Feb-2021 and was forwarded to Moderna on 19-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm really sore), FEELING JITTERY (jittery), PYREXIA (Fever of 100.1F (3 degrees warmer than typical temperature).), HEADACHE (headache) and NAUSEA (nausea) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included OMEPRAZOLE for an unknown indication.   On 16-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Feb-2021, the patient experienced PAIN IN EXTREMITY (arm really sore) and PYREXIA (Fever of 100.1F (3 degrees warmer than typical temperature).). On 19-Feb-2021, the patient experienced FEELING JITTERY (jittery), HEADACHE (headache) and NAUSEA (nausea). At the time of the report, PAIN IN EXTREMITY (arm really sore) outcome was unknown and FEELING JITTERY (jittery), PYREXIA (Fever of 100.1F (3 degrees warmer than typical temperature).), HEADACHE (headache) and NAUSEA (nausea) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-Feb-2021, Pyrexia: 100.1f (High) 100.1F. On 19-Feb-2021, Pyrexia: 98.1f (normal) 98.1F.         Treatment information was provided as acetaminophen.
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Pyrexia
Clinical narrative: Chills; Temperature of 100; A report was received from a consumer concerning a  female patient who experienced Chills and Fever.   The patient reporter, included no any historical conditions. No relevant concomitant medications were reported.   After the first dose of mRNA-1273,  Adverse event was reported which is crosslinked to MOD21-01675. There was no change planned to the dosing schedule of mRNA-1273 in response to the events.  The patient received their second of two planned doses of mRNA-1273 vaccine on 26 JAN 2021 for prophylaxis of COVID-19 infection.   It was reported that she experienced chills and a temperature of 100 after receiving her second dose on 26Jan2021. No treatment information was provided.     The patient received both scheduled doses of mRNA-1273 prior to this  events The outcome of the events were unknown.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Discomfort, Dry skin, Erythema, Feeling abnormal, Pain in extremity
Clinical narrative: redness is getting bigger; is actually very swollen; it's uncomfortable; it's really really hot; it got red; it was kind of swelling; arm was a little hurting; there was some discomfort; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm was a little hurting), DISCOMFORT (there was some discomfort), ERYTHEMA (it got red), SWELLING (it was kind of swelling) and ERYTHEMA (redness is getting bigger) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for an unknown indication. The occurrence of additional non-serious events is detailed below.     no medical history was reported.  Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) and ERGOCALCIFEROL, RETINOL PALMITATE (VITAMINS A & D) for an unknown indication.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Feb-2021, the patient experienced PAIN IN EXTREMITY (arm was a little hurting) and DISCOMFORT (there was some discomfort). On 18-Feb-2021, the patient experienced ERYTHEMA (it got red), SWELLING (it was kind of swelling) and DRY SKIN (it's really really hot). On 19-Feb-2021, the patient experienced ERYTHEMA (redness is getting bigger), PERIPHERAL SWELLING (is actually very swollen) and FEELING ABNORMAL (it's uncomfortable). On 13-Feb-2021, PAIN IN EXTREMITY (arm was a little hurting) and DISCOMFORT (there was some discomfort) had resolved. At the time of the report, ERYTHEMA (it got red), SWELLING (it was kind of swelling), ERYTHEMA (redness is getting bigger), PERIPHERAL SWELLING (is actually very swollen), FEELING ABNORMAL (it's uncomfortable) and DRY SKIN (it's really really hot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.    Treatment details included None.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling, Swelling
Clinical narrative: redness is getting bigger; is actually very swollen; it's uncomfortable; it's really really hot; it got red; it was kind of swelling; arm was a little hurting; there was some discomfort; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm was a little hurting), DISCOMFORT (there was some discomfort), ERYTHEMA (it got red), SWELLING (it was kind of swelling) and ERYTHEMA (redness is getting bigger) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for an unknown indication. The occurrence of additional non-serious events is detailed below.     no medical history was reported.  Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) and ERGOCALCIFEROL, RETINOL PALMITATE (VITAMINS A & D) for an unknown indication.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Feb-2021, the patient experienced PAIN IN EXTREMITY (arm was a little hurting) and DISCOMFORT (there was some discomfort). On 18-Feb-2021, the patient experienced ERYTHEMA (it got red), SWELLING (it was kind of swelling) and DRY SKIN (it's really really hot). On 19-Feb-2021, the patient experienced ERYTHEMA (redness is getting bigger), PERIPHERAL SWELLING (is actually very swollen) and FEELING ABNORMAL (it's uncomfortable). On 13-Feb-2021, PAIN IN EXTREMITY (arm was a little hurting) and DISCOMFORT (there was some discomfort) had resolved. At the time of the report, ERYTHEMA (it got red), SWELLING (it was kind of swelling), ERYTHEMA (redness is getting bigger), PERIPHERAL SWELLING (is actually very swollen), FEELING ABNORMAL (it's uncomfortable) and DRY SKIN (it's really really hot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.    Treatment details included None.
Sex: M
Vaccine: COVID19
Symptoms: Discomfort, Feeling hot, Vaccination site pain
Clinical narrative: hot feeling; pressure between shoulder blades; sore arm; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 19-Feb-2021 and was forwarded to Moderna on 19-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (hot feeling), DISCOMFORT (pressure between shoulder blades) and VACCINATION SITE PAIN (sore arm) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FEELING HOT (hot feeling), DISCOMFORT (pressure between shoulder blades) and VACCINATION SITE PAIN (sore arm). At the time of the report, FEELING HOT (hot feeling), DISCOMFORT (pressure between shoulder blades) and VACCINATION SITE PAIN (sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 88.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Erythema, Fatigue, Myalgia, Pyrexia
Clinical narrative: hot rash; Chills; Fever; Fatigue; rash from shoulder to elbow; rash on arm; itchy rash on arm; redness; soreness; A spontaneous report was received from a consumer concerning a 88-years-old  patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events redness, soreness, rash on arm, itchy rash on arm, hot rash, swollen rash, chills, fever, fatigue, rash from shoulder to elbow.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 31 Jan 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 007M20A or MRN4544) intramuscularly for prophylaxis of COVID-19 infection.  On 1 Feb 2021, the patient experienced the event(s) redness, soreness. On 8 Feb 2021, the patient experienced the event(s) rash on arm, itchy rash on arm. On an unknown date, the patient experienced the event(s) hot rash, swollen rash, chills, fever, fatigue. On 14 Feb 2021, the patient experienced the event(s) rash from shoulder to elbow.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), redness, soreness, rash on arm, itchy rash on arm, hot rash, swollen rash, chills, fever, fatigue, rash from shoulder to elbow was unknown.
Age: 88.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Rash pruritic
Clinical narrative: hot rash; Chills; Fever; Fatigue; rash from shoulder to elbow; rash on arm; itchy rash on arm; redness; soreness; A spontaneous report was received from a consumer concerning a 88-years-old  patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events redness, soreness, rash on arm, itchy rash on arm, hot rash, swollen rash, chills, fever, fatigue, rash from shoulder to elbow.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 31 Jan 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 007M20A or MRN4544) intramuscularly for prophylaxis of COVID-19 infection.  On 1 Feb 2021, the patient experienced the event(s) redness, soreness. On 8 Feb 2021, the patient experienced the event(s) rash on arm, itchy rash on arm. On an unknown date, the patient experienced the event(s) hot rash, swollen rash, chills, fever, fatigue. On 14 Feb 2021, the patient experienced the event(s) rash from shoulder to elbow.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), redness, soreness, rash on arm, itchy rash on arm, hot rash, swollen rash, chills, fever, fatigue, rash from shoulder to elbow was unknown.
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: Got covid-19 after vaccination; A spontaneous report was received from other health professional concerning a male patient of unspecified age who received Moderna's COVID-19 vaccine (mRNA-1273) and tested positive for covid-19.  The patient's medical history and concomitant medication were not reported.  On 04-Jan-2021 prior to the onset of the event, the patient received their first of two planned doses of mRNA-1273 (Lot number: unknown) via intramuscular route for prophylaxis of COVID-19 infection.   A few days after the vaccine administration, the patient had sore throat, cough and body aches. Hence, on 08-Jan-2021, he went to the physician and had a strep test and covid-19 test. He did not have strep; but, however, he was positive for covid-19. No treatment information was provided.  Action taken with the mRNA-1273 in response to the event was not provided.   The outcome of event got covid-19 after vaccination was considered unknown.; Reporter's Comments: Based on the current available information and the mechanism of action of mRNA-1237 vaccine, the event of COVID-19 is assessed as unlikely related.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: developed a lump under his armpit; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (developed a lump under his armpit) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for an unknown indication.     No Medical History information was reported.    On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced LYMPHADENOPATHY (developed a lump under his armpit). At the time of the report, LYMPHADENOPATHY (developed a lump under his armpit) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication were provided by reporter   Reporter did not allow further contact
Sex: M
Vaccine: COVID19
Symptoms: Abdominal discomfort, Body temperature, Chills, Diarrhoea, Headache
Clinical narrative: stomach upset; fever; cold; chills; Muscle stiffness; vomiting; diarrhea; Headaches; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headaches), PYREXIA (fever), NASOPHARYNGITIS (cold), CHILLS (chills) and MUSCULOSKELETAL STIFFNESS (Muscle stiffness) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hypertension and Allergy (Allergic to Amoxicillin, Sodium-penicillin, oxycodone, and outside things.). Concomitant products included LORATADINE for Allergy, METOPROLOL for Hypertension, AMLODIPINE BESILATE (PRODIPINE).    On 24-Jan-2021 at 1:15 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Jan-2021, the patient experienced HEADACHE (Headaches), NASOPHARYNGITIS (cold), CHILLS (chills), MUSCULOSKELETAL STIFFNESS (Muscle stiffness), VOMITING (vomiting) and DIARRHOEA (diarrhea). On 25-Jan-2021, the patient experienced PYREXIA (fever). On an unknown date, the patient experienced ABDOMINAL DISCOMFORT (stomach upset). On 24-Jan-2021, HEADACHE (Headaches) outcome was unknown, MUSCULOSKELETAL STIFFNESS (Muscle stiffness) had resolved. At the time of the report, PYREXIA (fever), NASOPHARYNGITIS (cold), CHILLS (chills), ABDOMINAL DISCOMFORT (stomach upset) and VOMITING (vomiting) had resolved and DIARRHOEA (diarrhea) outcome was unknown. For Callers mother and husband this symptom appeared after taking Moderna's COVID 19 vaccine.    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 25-Jan-2021, Body temperature increased: 101 degree f.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       As treatment for the events she has also taken Tylenol.   This case was linked to MOD-2021-017362, MOD-2021-018532 (Patient Link).
Sex: M
Vaccine: COVID19
Symptoms: Musculoskeletal stiffness, Nasopharyngitis, Pyrexia, Vomiting
Clinical narrative: stomach upset; fever; cold; chills; Muscle stiffness; vomiting; diarrhea; Headaches; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headaches), PYREXIA (fever), NASOPHARYNGITIS (cold), CHILLS (chills) and MUSCULOSKELETAL STIFFNESS (Muscle stiffness) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hypertension and Allergy (Allergic to Amoxicillin, Sodium-penicillin, oxycodone, and outside things.). Concomitant products included LORATADINE for Allergy, METOPROLOL for Hypertension, AMLODIPINE BESILATE (PRODIPINE).    On 24-Jan-2021 at 1:15 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Jan-2021, the patient experienced HEADACHE (Headaches), NASOPHARYNGITIS (cold), CHILLS (chills), MUSCULOSKELETAL STIFFNESS (Muscle stiffness), VOMITING (vomiting) and DIARRHOEA (diarrhea). On 25-Jan-2021, the patient experienced PYREXIA (fever). On an unknown date, the patient experienced ABDOMINAL DISCOMFORT (stomach upset). On 24-Jan-2021, HEADACHE (Headaches) outcome was unknown, MUSCULOSKELETAL STIFFNESS (Muscle stiffness) had resolved. At the time of the report, PYREXIA (fever), NASOPHARYNGITIS (cold), CHILLS (chills), ABDOMINAL DISCOMFORT (stomach upset) and VOMITING (vomiting) had resolved and DIARRHOEA (diarrhea) outcome was unknown. For Callers mother and husband this symptom appeared after taking Moderna's COVID 19 vaccine.    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 25-Jan-2021, Body temperature increased: 101 degree f.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       As treatment for the events she has also taken Tylenol.   This case was linked to MOD-2021-017362, MOD-2021-018532 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Pain in extremity, Pyrexia, Skin warm
Clinical narrative: sore arm; Neck and stomach were burning like fever; fever 100F; This spontaneous case was reported by a consumer and describes the occurrence of SKIN WARM (Neck and stomach were burning like fever), PYREXIA (fever 100F) and PAIN IN EXTREMITY (sore arm) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025L20A and 043L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 31-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced SKIN WARM (Neck and stomach were burning like fever), PYREXIA (fever 100F) and PAIN IN EXTREMITY (sore arm). At the time of the report, SKIN WARM (Neck and stomach were burning like fever), PYREXIA (fever 100F) and PAIN IN EXTREMITY (sore arm) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: body temperature 100F fever was reported.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not reported  Treatment for the events were  acetaminophen included
Age: 30.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: tested postive for covid-19 after 1st dose; This spontaneous case was reported by a nurse and describes the occurrence of COVID-19 (tested postive for covid-19 after 1st dose) in a 30-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K02A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Jan-2021, the patient experienced COVID-19 (tested postive for covid-19 after 1st dose). On 16-Jan-2021, COVID-19 (tested postive for covid-19 after 1st dose) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 04-Jan-2021, Severe acute respiratory syndrome: Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications used by the patient was not reported.   No Treatment details was provided.
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Pain in extremity, Pyrexia, Skin warm
Clinical narrative: Neck and stomach were burning like fever; sore; fever 100F; This spontaneous case was reported by a consumer and describes the occurrence of SKIN WARM (Neck and stomach were burning like fever), PAIN IN EXTREMITY (sore) and PYREXIA (fever 100F) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025L20A and 043L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 31-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced SKIN WARM (Neck and stomach were burning like fever), PAIN IN EXTREMITY (sore) and PYREXIA (fever 100F). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, SKIN WARM (Neck and stomach were burning like fever), PAIN IN EXTREMITY (sore) and PYREXIA (fever 100F) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: body temperature 100F was reported..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information include Tylenol.Concomitant medications were not reported.   This case was linked to MOD-2021-018772 (Patient Link).
Sex: M
Vaccine: COVID19
Symptoms: Back pain, Chills, Dizziness, Hypoaesthesia, Influenza like illness
Clinical narrative: back pain; pain in neck; pain in jaw; numbness in hand; can not clench his hand; fever; Chills; dizziness; flu like symptoms; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 19-Feb-2021 and was forwarded to Moderna on 20-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness), INFLUENZA LIKE ILLNESS (flu like symptoms), BACK PAIN (back pain), NECK PAIN (pain in neck) and PAIN IN JAW (pain in jaw) in a 38-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026L20A and 030L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Feb-2021, the patient experienced DIZZINESS (dizziness), INFLUENZA LIKE ILLNESS (flu like symptoms), PYREXIA (fever) and CHILLS. On 10-Feb-2021, the patient experienced BACK PAIN (back pain), NECK PAIN (pain in neck), PAIN IN JAW (pain in jaw), HYPOAESTHESIA (numbness in hand) and JOINT STIFFNESS (can not clench his hand). At the time of the report, DIZZINESS (dizziness), INFLUENZA LIKE ILLNESS (flu like symptoms), BACK PAIN (back pain), NECK PAIN (pain in neck), PAIN IN JAW (pain in jaw), HYPOAESTHESIA (numbness in hand), JOINT STIFFNESS (can not clench his hand), PYREXIA (fever) and CHILLS outcome was unknown.            Reporter did not allow further contact
Sex: M
Vaccine: COVID19
Symptoms: Joint stiffness, Neck pain, Pain in jaw, Pyrexia
Clinical narrative: back pain; pain in neck; pain in jaw; numbness in hand; can not clench his hand; fever; Chills; dizziness; flu like symptoms; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 19-Feb-2021 and was forwarded to Moderna on 20-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness), INFLUENZA LIKE ILLNESS (flu like symptoms), BACK PAIN (back pain), NECK PAIN (pain in neck) and PAIN IN JAW (pain in jaw) in a 38-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026L20A and 030L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Feb-2021, the patient experienced DIZZINESS (dizziness), INFLUENZA LIKE ILLNESS (flu like symptoms), PYREXIA (fever) and CHILLS. On 10-Feb-2021, the patient experienced BACK PAIN (back pain), NECK PAIN (pain in neck), PAIN IN JAW (pain in jaw), HYPOAESTHESIA (numbness in hand) and JOINT STIFFNESS (can not clench his hand). At the time of the report, DIZZINESS (dizziness), INFLUENZA LIKE ILLNESS (flu like symptoms), BACK PAIN (back pain), NECK PAIN (pain in neck), PAIN IN JAW (pain in jaw), HYPOAESTHESIA (numbness in hand), JOINT STIFFNESS (can not clench his hand), PYREXIA (fever) and CHILLS outcome was unknown.            Reporter did not allow further contact
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Peripheral swelling, Vaccination site erythema, Vaccination site inflammation, Vaccination site warmth
Clinical narrative: Entire arm became sore; deltoid muscle was inflammed; It was hot to touch (deltoid muscle); Arm puffed up and swollen; bright red like a sunburn (deltoid muscle); This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Entire arm became sore), PERIPHERAL SWELLING (Arm puffed up and swollen), VACCINATION SITE INFLAMMATION (deltoid muscle was inflammed), VACCINATION SITE WARMTH (It was hot to touch (deltoid muscle)) and VACCINATION SITE ERYTHEMA (bright red like a sunburn (deltoid muscle)) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced PAIN IN EXTREMITY (Entire arm became sore), PERIPHERAL SWELLING (Arm puffed up and swollen), VACCINATION SITE INFLAMMATION (deltoid muscle was inflammed), VACCINATION SITE WARMTH (It was hot to touch (deltoid muscle)) and VACCINATION SITE ERYTHEMA (bright red like a sunburn (deltoid muscle)). The patient was treated with DICLOFENAC (VOLTAREN [DICLOFENAC]) at a dose of 50 mg. At the time of the report, PAIN IN EXTREMITY (Entire arm became sore) had not resolved and PERIPHERAL SWELLING (Arm puffed up and swollen), VACCINATION SITE INFLAMMATION (deltoid muscle was inflammed), VACCINATION SITE WARMTH (It was hot to touch (deltoid muscle)) and VACCINATION SITE ERYTHEMA (bright red like a sunburn (deltoid muscle)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to MOD-2021-029752, MOD-2021-029752 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 27-Feb-2021: Follow-up added on 27-Feb-2021 included: Additional AEs added. Outcome of pain in arm updated.
Sex: F
Vaccine: COVID19
Symptoms: Computerised tomogram head, Hypoaesthesia, Paraesthesia
Clinical narrative: Hypoaesthesia; Tingling; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of HYPOAESTHESIA (Hypoaesthesia) and PARAESTHESIA (Tingling) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN), ATORVASTATIN, ANASTROZOLE (ARIMIDEX) and HYDROCHLOROTHIAZIDE, OLMESARTAN MEDOXOMIL (OLMESARTAN + HIDROCLOROTIAZIDA) for an unknown indication.    On 31-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Jan-2021, the patient experienced HYPOAESTHESIA (Hypoaesthesia) and PARAESTHESIA (Tingling). At the time of the report, HYPOAESTHESIA (Hypoaesthesia) and PARAESTHESIA (Tingling) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Computerised tomogram head: ct scan Negative brain normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment for the event included Carbamazepine .
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Dizziness, Injection site bruising, Injection site erythema, Injection site swelling
Clinical narrative: mark on her arm at injection site; Weakness; Dizziness; injection site is big; (mark) is red; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE BRUISING (mark on her arm at injection site), ASTHENIA (Weakness), DIZZINESS (Dizziness), INJECTION SITE SWELLING (injection site is big) and INJECTION SITE ERYTHEMA ((mark) is red) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.  On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE BRUISING (mark on her arm at injection site), ASTHENIA (Weakness), DIZZINESS (Dizziness), INJECTION SITE SWELLING (injection site is big) and INJECTION SITE ERYTHEMA ((mark) is red). At the time of the report, INJECTION SITE BRUISING (mark on her arm at injection site), ASTHENIA (Weakness), DIZZINESS (Dizziness) and INJECTION SITE SWELLING (injection site is big) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   No relevant concomitant medications are provided.  No treatment information reported.